2nd Quarter - Report

VAN SCOYOC ASSOCIATES for MEDICINES FOR MALARIA VENTURE

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Public Law 112-8, Further Additional Continuing Appropriations Amendments, FY2011, USAID and Malaria research and development issues and initiatives. Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY2011, USAID and Malaria research and development issues and initiatives. Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2012, USAID and Malaria research and development issues and initiatives. Department of State, Foreign Operations, and Related Programs Appropriations Act, FY2012, USAID and Malaria research and development issues and initiatives.

Foreign entity interest: All registered foreign entities have an interest in the cause, treatment and cure of malaria.

LobbyistCovered position, as disclosed
EDWARD LONG —
MARK TAVLARIDES —
GREG VAN SCOYOC —
H STEWART VAN SCOYOC —

Contacted: SENATE; Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID)

Medical/Disease Research/Clinical Labs MED

USAID and Malaria research and development issues and initiatives

Foreign entity interest: All registered foreign entities have an interest in the cause, treatment and cure of malaria.

LobbyistCovered position, as disclosed
EDWARD LONG —
MARK TAVLARIDES —
GREG VAN SCOYOC —
H STEWART VAN SCOYOC —

Contacted: HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID); SENATE; Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.